Home › Focal Segmental Glomerulosclerosis › New York
Focal Segmental Glomerulosclerosis clinical trials in New York
11 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in New York.
Cities in New York
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Columbia University Irving Medical Center- Site Number : 8400001, New York
- The Children's Hospital at Montefiore- Site Number : 8400027, The Bronx
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- New York Nephrology and Dialysis Access Surgery, PC, Clifton Park
- NYU Langone Nephrology Associates-Mineola, Mineola
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT07220083Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Weill Cornell Medical Center / NewYork-Presbyterian, New York
Recruiting
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT02235857Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Weill Cornell Medicine / NewYork-Presbyterian, New York
Recruiting
Up to age 75 · All sexes · Updated Aug 28, 2026 · NCT04065438NEPTUNE Match Study
- Northwell/Cohen's Children's Hospital, New Hyde Park
- Columbia University Medical Center, New York
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Cohen Children's Hospital, New Hyde Park
- New York University Medical Center, New York
- Bellevue Hospital, New York
- and 3 more
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cohen Children's Medical Center, New Hyde Park
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
- Cohen Children's Medical Center, New Hyde Park
Recruiting
Ages 3 to 17 · All sexes · Updated Apr 17, 2026 · NCT05583942taVNS for FRNS in Children
- Cohen Children's Medical Center, New Hyde Park
Recruiting
Ages 3 to 17 · All sexes · Updated Apr 15, 2026 · NCT05588063AMPK-activation by Metformin in FSGS: AMP-FSGS
- Mount Sinai Hospital, New York
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Feb 3, 2026 · NCT06090227A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Feb 3, 2026 · NCT05183646From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.